MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on every 2026 Illinois Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Illinois cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

HIV treatment and prevention by 2026 Illinois Part D plan
DrugWellcare Classic$0.00/moS4802-087Wellcare Value Script$0.00/moS4802-151Humana Basic Rx Plan$0.00/moS5884-107Humana Value Rx Plan$0.00/moS5884-196AARP Medicare Rx Saver from UHC$40.20/moS5921-362HealthSpring Extra Rx$66.60/moS5617-367Blue Cross MedicareRx Basic$89.70/moS5715-012SilverScript Choice$94.90/moS5601-034AARP Medicare Rx Preferred from UHC$103.90/moS5921-398HealthSpring Assurance Rx$104.20/moS5617-224Humana Premier Rx Plan$119.40/moS5884-163Blue Cross MedicareRx Value$119.70/moS5715-001
Biktarvybictegravir/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 525%QL 30/30d
Dovatodolutegravir and lamivudineTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 525%QL 30/30d
Triumeqabacavir/dolutegravir/lamivudineTier 431%Tier 440%Tier 434%QL 180/30dTier 435%QL 180/30dTier 439%QL 180/30dTier 430%QL 300/30dTier 443%QL 180/30dTier 433%Tier 438%QL 180/30dTier 432%QL 300/30dTier 450%QL 180/30dTier 432%QL 180/30d
Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%QL 30/30d
Odefseyemtricitabine/rilpivirine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%QL 30/30d
Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 525%QL 30/30d
Julucadolutegravir and rilpivirineTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 525%QL 30/30d
Descovyemtricitabine and tenofovir alafenamideTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%QL 30/30d
Truvadaemtricitabine and tenofovir disoproxilNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
emtricitabine-tenofovirgeneric TruvadaTier 431%QL 30/30dTier 440%QL 30/30dTier 434%QL 30/30dTier 435%QL 30/30dTier 439%QL 30/30dTier 430%QL 30/30dTier 443%QL 30/30dTier 433%QL 30/30dTier 438%QL 30/30dTier 432%QL 30/30dTier 450%QL 30/30dTier 432%QL 30/30d
TivicaydolutegravirTier 525%Tier 525%Tier 525%QL 60/30dTier 526%QL 60/30dTier 525%QL 60/30dTier 430%QL 180/30dTier 525%QL 60/30dTier 525%Tier 531%QL 60/30dTier 432%QL 180/30dTier 533%QL 60/30dTier 525%QL 60/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.